Case Study: Achieving 120% of Enrollment Targets for a Teen Cytomegalovirus (CMV) Trial at 5 Sites

Achieving 120 Percent of Enrollment Targets for Teen CMV Trial at 5 Sites

Overview Tekton contributed five clinical research sites to a sponsor-led adolescent CMV vaccine study, each with an enrollment goal of eight participants. Through strategic recruitment, proactive site engagement, and streamlined regulatory operations, Tekton achieved 120% of its enrollment target, enrolling a total of 48 participants in the study. Key Metrics 120% Average enrollment across 5 … Read more